Z. Ergul Yilmazab,
S. Vanslambrouckac,
S. Cajota,
J. Thirya,
A. Debuignea,
P. Lecomteac,
C. Jérôme*a and
R. Rivaa
aCenter for Education and Research on Macromolecules (CERM), University of Liège, Chemistry Department, building B6a Sart-Tilman, B-4000 Liège, Belgium. E-mail: c.jerome@ulg.ac.be
bINSERM U1066, Micro et Nanomédecines Biomimétiques, IBS, University of Angers, 4 rue Larrey, Cedex 9, Angers, 49933, France
cBioMIMedics, Interreg EMR IV-A Consortium: Lead Partner Maastricht University, Universiteitssingel 50, 6229ER Maastricht, The Netherlands
First published on 13th April 2016
Poly(ethylene oxide)-b-polyphosphoester amphiphilic block copolymers are known to self-assemble into polymer micelles when dissolved in water. This work aims at reporting on the improvement of the stability of the micelles at high dilution by crosslinking the hydrophobic polyphosphoester micellar core. Typically, an unsaturated alkene side-chain was introduced onto the cyclic phosphate monomer according to a one-step reaction followed by its organocatalyzed polymerization initiated by a poly(ethylene oxide) macroinitiator. This strategy avoids the use of any organometallic compounds in order to facilitate the purification and meet the stringent requirements of biomedical applications. After self-assembly in water, the micelles were cross-linked by simple UV irradiation. These cross-linked micelles have then been loaded with doxorubicin to evaluate their potential as drug nanocarriers and monitor the impact of crosslinking on the release profile.
Needless to say that the polymer constituents of such nanocarriers, must be biocompatible and biodegradable or bioeliminable. For nanocarriers to comply with the stealthiness, the hydrophilic block of amphiphilic block copolymers is usually a biocompatible and bioeliminable short length poly(ethylene oxide) (PEO). Beside, a biocompatible and biodegradable aliphatic polyester, such as poly(ε-caprolactone) (PCL) and polylactides (PLA) is mostly used as the hydrophobic block.5 As a consequence, PEO-b-aliphatic polyester copolymers are the family of amphiphilic block copolymers among the most studied worldwide for the elaboration of biodegradable micelles based-nanocarriers.6–8 Therefore, functional aliphatic polyesters modified by reactive side-groups have been synthesized to build cross-linked micelles that can be efficiently used as drug nanocarriers.9,10
Nevertheless, the hydrolytic degradation of PCL and PLA has an impact on the local pH, which locally decreases due to the degradation products accumulation.11–13 This acidification may have undesirable side-effect on living tissues. Recently, a new class of biodegradable polymers, i.e. polyphosphoesters (PPE),14–16 is emerging as a valuable alternative towards polyesters. Like polyesters, polyphosphoesters are attractive for biomedical applications such as drug delivery,17–19 gene delivery,20–22 tissue engineering23–25 and dental applications23 because of their biocompatibility and biodegradability and their structural similarities to nucleic and teichoic acids.26–28 Their degradation does not change significantly the local pH.14,29,30 Similarly to aliphatic polyesters, they are easily synthesized by organocatalyzed ring-opening polymerization (ROP) of cyclic phospholane monomers.26,31–33 Moreover, their functionalities and properties can be controlled by changing the pendant group on the pentavalent phosphorus atom of the cyclic phospholane monomer precursors.
Pioneer works of Wooley et al. demonstrated that PEO-b-PPE-based drug conjugates are able to form micelles with a high drug loading capacity.15 Besides, they also showed that the PEBP-b-PBYP-g-PEO amphiphilic block terpolymer was capable of carrying silver thanks to the presence of alkyne unsaturations on the polyphosphoester block.16 Therefore, inspired by these researches, we have designed and synthesized novel PEO-b-PPE amphiphilic block copolymers bearing unsaturations on the polyphosphoester block, in order to develop core cross-linked micelles as drug carrier of the second generation (Scheme 1).
![]() | ||
Scheme 1 Schematic representation of micelle construction via self-assembly of the amphiphilic block copolymers in water and crosslinking by UV irradiation, followed by loading with doxorubicin. |
Firstly, the homopolymerization of butenylphosphoester (BP) and the copolymerization of isobutylphosphoester (iBP) and BP initiated from monomethoxy-PEO (MPEO–OH) by using organocatalysis will be investigated for the first time. Organocatalysis has been especially selected for the ROP to avoid metal residues difficult to extract from the copolymer as a biomedical application is foreseen. Secondly, micellization of the copolymer and the crosslinking by UV irradiation will be studied by dynamic light scattering (DLS) and transmission electron microscopy (TEM). Especially, the stability of the cross-linked nanocarriers will be demonstrated by using good solvent of both blocks. Finally, the effect of the crosslinking of the micelles on the drug loading and release profile will be evaluated by using doxorubicin,34,35 a typical drug used in cancer therapy.
The PEO-b-polyBP amphiphilic copolymer was synthesized by initiation of the BP ROP starting from a MPEO–OH macroinitiator (Mn = 5000 g mol−1) as shown in Scheme 2 (route A). The latter was performed by organocatalyzed-ROP in the presence of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) and 1-1-[3,5-bis(trifluoromethyl)phenyl]-3-cyclohexyl-2-thiourea (TU) ([DBU]0/[TU]0 = 2). Substitution of organic compounds for metallic catalysts in the ROP prevents contamination of the final polymer by any metal traces that are incompatible with biomedical applications. Moreover, Clément et al. demonstrated the beneficial effect of using a DBU/TU mixture as catalysts for the polymerization of cyclic phospholanes on the polymerization kinetics and control.26 As a matter of fact, DBU and TU system minimized the intra- and inter-molecular transesterification side-reactions and appears as the most efficient catalytic method for this type of monomers. Following a procedure adapted from Clément et al.,26 the polymerization of BP was studied using MPEO–OH as an initiator. This macroinitiator being not very soluble in toluene at 0 °C, the ROP of BP was studied here in dichloromethane at 0 °C with both catalyst and co-catalyst.
![]() | ||
Scheme 2 General strategy for the synthesis of amphiphilic block copolymers with PEO as first block and poly(BP) (route A) or poly(BP) and poly(iBP) (route B) as second block. |
Amphiphilic block copolymers with a hydrophilic-lipophilic balance (HLB) around 15 are usually recommended when the parent micelles are intended for drug delivery applications.6 Indeed, when the molar mass of the hydrophilic PEO block is higher than the hydrophobic poly(BP) block (HLB>10), amphiphilic copolymers are prone to form spherical micelles. Therefore, because the molar mass of the MPEO–OH macroinitiator used in this study was equal to 5000 g mol−1, the BP/MPEO–OH molar ratio was adjusted to 12 corresponding to a molar mass of the polyphosphoester sequence of 1200 g mol−1 (HLB = 15). The conversion of BP monomer reached 87% when the polymerization was stopped after 20 minutes (Table 1).
Monomer | Catalyst | BP (mmol) | MPEO–OH (mmol) | Catalyst (mmol) | Time (min) | Conv. (%) | DP PPE blocka 1H NMR | Mn PPE blockb 1H NMR (g mol−1) | Đc (SEC) | HLB d |
---|---|---|---|---|---|---|---|---|---|---|
a Degree of polymerization for the polyphosphoester block determined by 1H NMR according to the following equation: DP = integral1H polyphosphate block/integral1H PEO block × 110.b Average molar mass of the polyphosphoester block determined according to the following equation: Mn = DPBP × 178.c Molar mass distribution determined by SEC.d HLB calculated by the Griffin equation 20 × [1 − (Mn,PPE block/Mn,total)]. | ||||||||||
BP | DBU/TU | 30 | 1 | 5/2 | 30 | 98 | 25 | 4500 | 1.1 | 5 |
BP | DBU/TU | 12 | 1 | 5/2.5 | 20 | 87 | 7 | 1200 | 1.2 | 15 |
Size exclusion chromatography (SEC) (Fig. 1A) shows the shift of the SEC trace towards higher molar masses after BP polymerization, which proved the successful chain extension by ROP from the MPEO–OH macroinitiator and the formation of the expected PEO-b-polyBP amphiphilic block copolymer. Broadening of the main peak was observed but an additional small peak was detected at lower elution volume compared to the major population. This higher molar mass peak results from the polymerization of BP initiated from traces of poly(ethylene oxide) having alcohol functions at both ends of the chain (HO-PEO–OH) which contaminates the commercial MPEO–OH as previously evidenced by the MALDI-TOF spectrum.31 Nevertheless, well-defined PEO110-b-polyBP7 (Mn SEC = 4900 g mol−1, Đ = 1.1) was obtained. The actual molar mass and composition of the copolymer was determined by 1H NMR (Fig. 2).
![]() | ||
Fig. 1 SEC traces in THF of the (A) MPEO110-b-polyBP7 and MPEO–OH, (B) PEO110-b-poly(iBP5-co-BP5) and MPEO–OH. |
Considering the relative intensities of the PEO peak at 3.6 ppm and the signal corresponding to the protons of the unsaturated pendant group (peak b, Fig. 2) of the BP units at 2.5 ppm, the average molar mass of the polyBP block was evaluated to 1200 g mol−1, which represents an average degree of polymerization (DP) of 7. Let us mentioned that to exemplify this diblock copolymerization, a second composition was tested starting from a BP/MPEO–OH molar ratio to 30 (Table 1), for which similar observations and conclusions can be drawn, i.e.; a fast polymerization leading to well-defined diblock copolymer with a composition close to the theoretical value and a narrow distribution of the molar masses. In that case, the HLB of the obtained diblock copolymer being only 5, this copolymer was not used further for micellization.
It is also worth to mention that if the cyclic monomer is very sensitive to water traces, the diblock copolymer can be kept in water without significant degradation over a period of several days as demonstrated by 1HNMR in D2O with time (Fig. S1†). This confirms that the copolymers can sustain purification dialysis without hydrolytic degradation at neutral pH.
In order to modulate the crosslinking density of the micelles and investigate its impact on the drug loading and release kinetics, amphiphilic block copolymers presenting a lower number of unsaturation along the polyphosphate backbone were synthesized (Scheme 2, route B). Typically, a part of the BP monomer was substituted by iBP monomer. In the conditions developed for the PEO-b-polyBP (DBU/TU catalytic system in CH2Cl2 at 0 °C), the ring-opening copolymerization of BP and iBP mixtures was performed with monomer ratios (iBP/BP) of 7/3, 5/5 and 3/7 (Table 2). The diblock copolymers were analysed by SEC (Fig. 1B, iBP/BP = 5/5), 1H and 31P NMR. The molar mass and the composition of the PEO110-b-poly(BP5-co-iBP5) block copolymers were measured by 1H NMR as illustrated for the iBP/BP ratio of 5/5 in Fig. 3.
Monomer | Catalyst | [iBP]0/[BP]0a (%) | MPEO–OH (mmol) | Catalyst (mmol) | Time (min) | Conv. (%) | DP PPE blockb | Number of vinyl group/chainc | [iBP]0/[BP]0d (%) | Mn PPE blocke 1H NMR (g mol−1) | Đf (SEC) |
---|---|---|---|---|---|---|---|---|---|---|---|
a Monomer ratio in the comonomer feed.b Degree of polymerization for the polyphosphoester block determined by 1H NMR according to the following equation: DP = integral1H polyphosphate block/integral1H PEO block × 110.c Number of vinylic function on the polyphosphoester block.d Composition of the polyphosphoester block determined by 1H NMR.e Average molar mass of the polyphosphoester block determined according to the following equation: Mn = DPBP × 178 + DPiBP × 178.f Molar mass distribution determined by SEC. | |||||||||||
iBP/BP | DBU/TU | 70/30 | 1 | 5/2.5 | 20 | 92 | 10 | 3 | 66/34 | 1800 | 1.1 |
iBP/BP | DBU/TU | 50/50 | 1 | 5/2.5 | 20 | 94 | 10 | 5 | 46/54 | 1800 | 1.1 |
iBP/BP | DBU/TU | 30/70 | 1 | 5/2.5 | 20 | 91 | 7 | 5 | 30/70 | 1200 | 1.1 |
The average size (Dh,app) of the self-assembled micelles in water was about 100 nm (PDI = 0.2), thus a comparable size (126 nm) of PEO114-b-poly(butyl phosphate)9 micelles of comparable composition and DP.33 This apparent hydrodynamic diameter decreased by 10 nm after crosslinking (PDI = 0.2), which suggests that the crosslinking reaction is responsible for a higher compactness of the polyBP chains in the micelles core. As expected, a spherical morphology of the cross-linked micelles was observed by TEM in agreement with the relative length of the blocks (Fig. 4).
The phosphorus atoms in the hydrophobic core provided it with a high contrast, whereas the PEO corona was collapsed and is unobserved.
The efficiency of the core crosslinking reaction was also assessed by the resistance of the cross-linked micelles against solubilization in DMF, a good solvent for both PEO and polyBP blocks. After a lyophilization step, the cross-linked micelles were dispersed into DMF. A substantial increase in size, from 100 nm in water up to 230 nm in DMF was observed by DLS (Fig. 5), which can be at least partly explained by the swelling of the polyphosphate core by DMF. The same analysis was also performed on the micelles irradiated but without addition of benzophenone. In that case, no nanoparticles the complete dissolution of the copolymer was observed in DMF evidencing the absence of crosslinking in these conditions.
![]() | ||
Fig. 5 Size distribution of the PEO-b-polyBP self-assembled micelles in H2O (![]() ![]() ![]() |
The key advantage of polymer micelles relies on their ability to encapsulate a hydrophobic drug inside their core. Doxorubicin base (DOX) was physically entrapped into the hydrophobic inner core of the micelles by hydrophobic interactions with the pendent group of the polyphosphotriester block.34,37 Advantageously, doxorubicin was easily quantified by UV-Vis absorption. Generally, drug loaded micelles are prepared by dissolution of the drug and the amphiphilic block copolymer into a common organic solvent followed by the rapid addition of water leading to the micelle formation concomitant to the encapsulation of the hydrophobic drug inside. This process is usually referred as nanoprecipitation process. In case of non-cross-linked micelles, such procedure could be applied to all the copolymers. Nevertheless, the cross-linked micelles led us to follow a drug impregnation process to load the DOX into the cross-linked systems. Typically, after UV crosslinking of the self-assembled micelles in water, the cross-linked micelles were collected by lyophilization before to be immersed into a doxorubicin solution in DMF. This process allows to avoid possible degradation of the drug during UV curing.
Looking at the loading data for micelles before crosslinking (Table 3), we can conclude that the number of vinyl functions on the polyphosphate backbone has a marked influence on the LC of doxorubicin. Indeed, for an identical polyphosphate molar mass (Table 3, entries A and B), an increase of the LC with the number of vinyl function was observed. This observation was confirmed when comparing entries C and D of Table 3, where a significant increase of the LC is observed when the PPE block is exclusively constituted of polyBP. Secondary interactions of doxorubicin with the unsaturation present on the polyphosphate side-groups may be at the origin of this phenomenon. Nevertheless, this advantage is limited in case of cross-linked micelles since the double bonds disappeared upon the crosslinking reaction. Nevertheless, in case of cross-linked systems, the LC appears less dependent of the micelles composition and remarkably, the impregnation process leads to higher loading than the nanoprecipitation process that has to be applied for the non-cross-linked micelles (Fig. 6).
Samples | HLBa | Self-assembled micelles | Cross-linked micelles | |||||
---|---|---|---|---|---|---|---|---|
Dhb (nm) | PDIc | LCd (%) | Dhb (nm) | PDIc | LCd (%) | |||
a HLB calculated by the Griffin equation 20 × [1 − Mn,hydrophobic block/Mn,total].b Apparent hydrodynamic diameter measured by DLS.c Polydispersity index determined by DLS.d Loading content determined by UV spectroscopy. | ||||||||
A | PEO110-b-poly(BP3-co-iBP7) | 15.1 | 120 ± 2 | 0.173 | 0.76 ± 0.01 | 147 ± 3 | 0.177 | 1.44 ± 0.03 |
B | PEO110-b-poly(BP5-co-iBP5) | 15.1 | 110 ± 4 | 0.209 | 0.93 ± 0.03 | 113 ± 11 | 0.509 | 1.37 ± 0.02 |
C | PEO110-b-poly(BP5-co-iBP2) | 16.4 | 110 ± 5 | 0.268 | 0.82 ± 0.02 | 173 ± 7 | 0.273 | 1.21 ± 0.03 |
D | PEO110-b-poly(BP7) | 16.4 | 100 ± 4 | 0.273 | 1.45 ± 0.04 | 92 ± 10 | 0.568 | 1.26 ± 0.03 |
Interestingly, the doxorubicin release rate was slightly affected by the crosslinking of the core excepted for the PEO110-b-poly(BP3-co-iBP7) based cross-linked micelles, for which a slower release rate was observed after crosslinking (Fig. 7A). The origin of this particular behaviour may come from the lowest crosslinking density allowing a better swelling of the cross-linked core during impregnation leading to a deeper diffusion of doxorubicin in the cross-linked micelles. After elimination of the DMF by dialysis, the cross-linked core collapsed leading to an efficient trapping of the doxorubicin. Nevertheless, in each case, a rather slightly slower release rate was obtained after crosslinking. Crosslinking thus allows improving the drug loading thanks to impregnation process while preserving a controlled drug delivery of the entrapped drug.
1H NMR (CDCl3) 5.8 ppm (m, 1H, CH2CH–CH2), 5.1 ppm (m, 2H, CH2
CH–CH2), 4.4 ppm (m, 4H, O–CH2–CH2–O), 4.1 ppm (m, 2H, –O–CH2–CH2), 2.4 ppm (m, 2H, CH2–CH2–CH
CH2).
31P NMR (CDCl3): 17.44 ppm.
1H NMR (CDCl3): 4.4 ppm (m, 4H, O–CH2–CH2–O), 3.9 ppm (m, 2H, O–CH2–CH), 1.9 ppm (m, 1H, O–CH2–CH), 1.1 ppm (m, 6H, CH–(CH3)2).
31P NMR (CDCl3): 17.52 ppm.
1H NMR (CDCl3) 5.7 ppm (m, 7H, O–CH2–CH2–CHCH2), 5.1 ppm (m, 14H, O–CH2–CH2–CH
CH2), 4.3 ppm (m, 28H, P–O–CH2–CH2–O), 4.1 ppm (m, 14H, O–CH2–CH2–CH
CH2), 3.6 ppm (m, 440H, O–CH2–CH2–O (PEO)), 3.4 ppm (s, 3H, CH2–CH2–O–CH3), 2.5 ppm (m, 14H, O–CH2–CH2–CH
CH2).
31P NMR (CDCl3): −1.37 ppm.
Mn 1H NMR = 1200 g mol−1, Mn SEC = 4900 g mol−1, Đ = 1.2.
1H NMR (CDCl3): 5.6 ppm (m, 5H, O–CH2–CH2–CHCH2), 5.1 ppm (m, 10H, O–CH2–CH2–CH
CH2), 4.4–4.0 ppm (m, 20H, O–CH2–CH2–O, 10H, O–CH2–CH2–C), 3.9 ppm (m, 10H, O–CH2–CH–(CH3)2), 3.6 ppm (m, 440H, O–CH2–CH2–O), 3.4 ppm (s, 3H, CH2–CH2–O–CH3), 2.4 ppm (m, 10H, O–CH2–CH2–CH
CH2), 2 ppm (m, 5H, O–CH2–CH–(CH3)2), 1 ppm (m, 30H, O–CH2–CH–(CH3)2).
31P NMR (CDCl3): 1.37 ppm.
Mn 1H NMR = 1800 g mol−1, Mn SEC = 10000 g mol−1, Đ = 1.1.
Footnote |
† Electronic supplementary information (ESI) available. See DOI: 10.1039/c6ra07422g |
This journal is © The Royal Society of Chemistry 2016 |